Labroplasty with the long head of the biceps tendon for recurrent anterior shoulder instability with under 20% glenoid bone loss
Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss
This test uses labroplasty with the long head of the biceps tendon to see if it improves shoulder stability, function, and MRI findings in people with recurrent anterior instability and less than 20% glenoid bone loss.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 21 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Kasr El Aini Hospital Academic / other |
| Locations | 1 site (Cairo, Cairo Governorate) |
| Trial ID | NCT07488039 on ClinicalTrials.gov |
What this trial studies
This single-center interventional study performs arthroscopic labroplasty using the long head of the biceps tendon in patients who have recurrent anterior shoulder dislocations with subcritical glenoid bone loss (<20%) and thinned or deficient anterior labrum (Franceschi types 2–3). Participants will undergo the arthroscopic procedure at Kasr El Aini Hospital, attend regular postoperative clinic visits, and receive MRI at 6 months to document radiological outcomes. Functional outcome scores and recurrence of instability will be recorded to compare pre- and post-procedure status. The protocol excludes patients with critical glenoid bone loss, long head of biceps pathology, multidirectional instability, prior stabilization surgery, rotator cuff tears, fractures, arthritis, infection, or skeletal immaturity.
Who should consider this trial
Good fit: Ideal candidates are adults with recurrent anterior shoulder instability, Franceschi type 2–3 labral defects, subcritical glenoid bone loss (<20%), and a positive anterior apprehension test without prior arthroscopic stabilization or biceps tendon pathology.
Not a fit: Patients with >20% glenoid bone loss, long head of biceps tendon pathology, multidirectional instability, rotator cuff tears, prior stabilization surgery, shoulder arthritis, proximal humeral fractures, active infection, or who are skeletally immature are unlikely to benefit from this procedure.
Why it matters
Potential benefit: If successful, the procedure could improve shoulder stability and function for patients with subcritical bone loss and potentially avoid more invasive bony reconstruction.
How similar studies have performed: Small case series and biomechanical reports have suggested promise for biceps-based labral augmentation, but there are limited larger or controlled trials, so the approach is relatively novel in clinical study form.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation. * Franceschi types 2 and 3 labral defects * subcritical glenoid bone loss \<20% * positive anterior shoulder apprehension Exclusion Criteria: * Critical glenoid bones loss \>20% * Franceschi type 1 labral defect * concomitant long head of biceps tendon pathology * multidirectional instability * prior arthroscopic shoulder stabilization surgery * concomitant proximal humeral fractures * concomitant Rotator cuff tears * skeletally immature patients * glenoid pathology * Shoulder arthritis * active infection
Where this trial is running
Cairo, Cairo Governorate
- Kasr El Aini Hospital — Cairo, Cairo Governorate, Egypt (Recruiting)
Study contacts
- Study coordinator: Sherif Walid Ibrahim, Assistant Lecturer
- Email: sherif_shibl@yahoo.com
- Phone: +201271377782
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.